sensiTVT is a relatively new tape. The aim of this study is to analyze the objective and subjective outcome at one year follow-up.
Stress urinary incontinence (SUI) is defined as the involuntary leakage during physical activity and situations that result in an increase of abdominal pressure like sneezing, coughing or laughing and affects up to 25% of women. Currently there are a number of tapes on the market with GYNECARE TVT EXACT® (Tension free Vaginal Tape) and TVT- Obturator being one of the tapes with the highest subjective and objective cure rates and relatively low adverse events in women with normal sphincter pressure. Due to the recent FDA announcements several tapes have been withdrawn from the market and several new ones have been designed. Data from other tapes are available, however data especially from newer tapes is lacking.
Study Type
OBSERVATIONAL
Enrollment
35
The study is designed as a prospective single arm study. All women with an indication for suburethral tape placement for therapy of SUI and meeting the inclusion criteria will be offered study participation to record the objective outcome after one year.
Department of Obstetrics, Medical University Graz
Graz, Austria
objective success of stress urinary incontinence
determined by a standardized cough stress test at 300 ml bladder, a negative cough stress test is a success.
Time frame: one year
Subjective success as determined using the Patient Global Impression of Improvement questionnaire.
defined as very much improved/much improved (1,2) on the Patient Global Impression of Improvement scale, while any other response (improved, same, worse, or much worse- 3-7) will be considered as failures. The Patient Global Impression of Improvement is a seven item scale validated for incontinence.
Time frame: 3 months+ one year
Peri- and postoperative complications
any surgical complications recorded
Time frame: 3 months+ one year
Subjective incontinence cure rate using the Incontinence Outcome Questionnaire
The Incontinence Outcome Questionnaire was validated for postoperative assessment of quality of life after surgical treatment for stress urinary incontinence and has 27 items with lower scores indicating worse treatment outcome. The total score is calculated.
Time frame: 3 months+ one year
quality of life using the Kings Health Questionnaire
The Kings Health Questionnaire was validated in women with stress urinary incontinence and assesses the impact of incontinence on quality of life. The eight subscales ("domains") scored between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst); lower scores indicate better QoL. Success in terms of the study is defined as 10 points improvement on the total Kings Health Questionnaire score.
Time frame: 3 months+ one year
Subjective bother using the Patient Global Impression of Severity
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Patient Global Impression of Severity The Patient Global Impression of Severity is a 7-item urinary symptom severity scale that is used to rate the severity of a specific condition -a single-state scale. The higher the number the worse the outcome of subjective bother of stress urinary incontinence.
Time frame: 3 months+ one year
Patient satisfaction measured using a visual analogue scale
Patient satisfaction is defined as a score 8 to 10 on a 10-point visual analogue scale
Time frame: 3 months+ one year
Sexual health using the Pelvic Organ Prolapse Incontinence Sexual Questionnaire
The Pelvic Organ Prolapse Incontinence Sexual Questionnaire is a 20 item questionnaire and is the primary measure used to assess sexual function in women with urinary incontinence and prolapse. Mean subscale scores are calculated by summing the valid responses to items in the subscale and then divided by the number of items with valid responses. The higher the subscores, the worse the outcome.
Time frame: 3 months+ one year
Erosion rate
Erosion rate from the tape in the vagina or bladder
Time frame: 3 months+ one year
Reoperation rate
Reoperation rate
Time frame: 3 months+ one year
De novo urgency
De novo OAB- overactive bladder as determined by clinical history taking
Time frame: 3 months+ one year
De novo pain in the operated region
De novo pain in the operated region as determined by clinical history taking
Time frame: 3 months+ one year